View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsPierrel 配当と自社株買い配当金 基準チェック /06Pierrel配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Oct 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (91% net debt to equity). Large one-off items impacting financial results. Market cap is less than US$100m (€87.9m market cap, or US$93.1m).New Risk • Sep 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€87.3m market cap, or US$93.0m).New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€86.0m market cap, or US$92.0m).New Risk • Aug 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€85.4m market cap, or US$93.9m).お知らせ • Aug 02Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million.Pierrel S.p.A. (BIT:PRL) entered into agreements to acquire assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million on May 2, 2023. The purchase consideration payable in cash, is subject to closing and other adjustments. These local anesthetic products had annual sales in 2022 of approximately $30 million. The transaction, which is subject to information or consultation requirements with relevant works councils and other closing conditions, is expected to be completed in the third quarter of 2023. The impact of ongoing operations were not material to 3M's financial results.Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million. on August 1, 2023.Valuation Update With 7 Day Price Move • Jul 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.31, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 20x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.42, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 21x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Aug 07Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €4.83m (up 12% from 2Q 2021). Net loss: €1.00m (loss widened 329% from 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 3.1% growth forecast for the industry in Italy.Reported Earnings • Jun 11First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €5.99m (down 8.1% from 1Q 2021). Net income: €542.0k (down 42% from 1Q 2021). Profit margin: 9.1% (down from 14% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 14%, compared to a 5.8% growth forecast for the industry in Italy.Buying Opportunity • Jun 10Now 21% undervaluedOver the last 90 days, the stock is up 8.9%. The fair value is estimated to be €0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.4%. For the next 3 years, revenue is forecast to grow by 17% per annum. Earnings is also forecast to grow by 27% per annum over the same time period.分析記事 • May 26We Think Pierrel (BIT:PRL) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • May 02Full year 2021 earnings releasedFull year 2021 results: Revenue: €23.8m (up 30% from FY 2020). Net income: €2.94m (up 55% from FY 2020). Profit margin: 12% (up from 10% in FY 2020). The increase in margin was driven by higher revenue.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 18Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €4.96m (up 96% from 3Q 2020). Net income: €673.0k (up €1.31m from 3Q 2020). Profit margin: 14% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue.分析記事 • Aug 11Does Pierrel (BIT:PRL) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • May 01First quarter 2021 earnings released: EPS €0.004 (vs €0.003 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €6.52m (up 27% from 1Q 2020). Net income: €940.0k (up 34% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.分析記事 • Apr 05Here's Why Pierrel (BIT:PRL) Has A Meaningful Debt BurdenLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €18.3m (down 17% from FY 2019). Net income: €1.90m (down 15% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.分析記事 • Mar 10Introducing Pierrel (BIT:PRL), A Stock That Climbed 76% In The Last YearIf you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...Is New 90 Day High Low • Feb 15New 90-day high: €0.24The company is up 42% from its price of €0.17 on 17 November 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is flat over the same period.分析記事 • Feb 10Calculating The Fair Value Of Pierrel S.p.A. (BIT:PRL)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Pierrel S.p.A...分析記事 • Dec 30How Is Pierrel's (BIT:PRL) CEO Paid Relative To Peers?The CEO of Pierrel S.p.A. ( BIT:PRL ) is Fulvio Citaredo, and this article examines the executive's compensation...分析記事 • Dec 01These 4 Measures Indicate That Pierrel (BIT:PRL) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Nov 16Third quarter 2020 earnings released: €0.003 loss per shareThe company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2020 results: Revenue: €2.54m (down 54% from 3Q 2019). Net loss: €634.0k (down 489% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 19First half earnings releasedOver the last 12 months the company has reported total profits of €3.76m, up 252% from the prior year. Total revenue was €22.7m over the last 12 months, up 7.8% from the prior year.決済の安定と成長配当データの取得安定した配当: PRLの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: PRLの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Pierrel 配当利回り対市場PRL 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (PRL)n/a市場下位25% (IT)1.7%市場トップ25% (IT)4.5%業界平均 (Pharmaceuticals)2.7%アナリスト予想 (PRL) (最長3年)n/a注目すべき配当: PRLは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: PRLは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: PRLの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: PRLが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIT 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/01/24 19:17終値2024/01/24 00:00収益2023/06/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Pierrel S.p.A. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Luigi TardellaEnVent Capital Markets LimitedFabrizio BariniIntermonte SIM S.p.A.
New Risk • Oct 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (91% net debt to equity). Large one-off items impacting financial results. Market cap is less than US$100m (€87.9m market cap, or US$93.1m).
New Risk • Sep 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€87.3m market cap, or US$93.0m).
New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€86.0m market cap, or US$92.0m).
New Risk • Aug 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€85.4m market cap, or US$93.9m).
お知らせ • Aug 02Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million.Pierrel S.p.A. (BIT:PRL) entered into agreements to acquire assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million on May 2, 2023. The purchase consideration payable in cash, is subject to closing and other adjustments. These local anesthetic products had annual sales in 2022 of approximately $30 million. The transaction, which is subject to information or consultation requirements with relevant works councils and other closing conditions, is expected to be completed in the third quarter of 2023. The impact of ongoing operations were not material to 3M's financial results.Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million. on August 1, 2023.
Valuation Update With 7 Day Price Move • Jul 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.31, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 20x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.
Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.42, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 21x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 07Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €4.83m (up 12% from 2Q 2021). Net loss: €1.00m (loss widened 329% from 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 3.1% growth forecast for the industry in Italy.
Reported Earnings • Jun 11First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €5.99m (down 8.1% from 1Q 2021). Net income: €542.0k (down 42% from 1Q 2021). Profit margin: 9.1% (down from 14% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 14%, compared to a 5.8% growth forecast for the industry in Italy.
Buying Opportunity • Jun 10Now 21% undervaluedOver the last 90 days, the stock is up 8.9%. The fair value is estimated to be €0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.4%. For the next 3 years, revenue is forecast to grow by 17% per annum. Earnings is also forecast to grow by 27% per annum over the same time period.
分析記事 • May 26We Think Pierrel (BIT:PRL) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • May 02Full year 2021 earnings releasedFull year 2021 results: Revenue: €23.8m (up 30% from FY 2020). Net income: €2.94m (up 55% from FY 2020). Profit margin: 12% (up from 10% in FY 2020). The increase in margin was driven by higher revenue.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 18Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €4.96m (up 96% from 3Q 2020). Net income: €673.0k (up €1.31m from 3Q 2020). Profit margin: 14% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue.
分析記事 • Aug 11Does Pierrel (BIT:PRL) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • May 01First quarter 2021 earnings released: EPS €0.004 (vs €0.003 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €6.52m (up 27% from 1Q 2020). Net income: €940.0k (up 34% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
分析記事 • Apr 05Here's Why Pierrel (BIT:PRL) Has A Meaningful Debt BurdenLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €18.3m (down 17% from FY 2019). Net income: €1.90m (down 15% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
分析記事 • Mar 10Introducing Pierrel (BIT:PRL), A Stock That Climbed 76% In The Last YearIf you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...
Is New 90 Day High Low • Feb 15New 90-day high: €0.24The company is up 42% from its price of €0.17 on 17 November 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is flat over the same period.
分析記事 • Feb 10Calculating The Fair Value Of Pierrel S.p.A. (BIT:PRL)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Pierrel S.p.A...
分析記事 • Dec 30How Is Pierrel's (BIT:PRL) CEO Paid Relative To Peers?The CEO of Pierrel S.p.A. ( BIT:PRL ) is Fulvio Citaredo, and this article examines the executive's compensation...
分析記事 • Dec 01These 4 Measures Indicate That Pierrel (BIT:PRL) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Nov 16Third quarter 2020 earnings released: €0.003 loss per shareThe company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2020 results: Revenue: €2.54m (down 54% from 3Q 2019). Net loss: €634.0k (down 489% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 19First half earnings releasedOver the last 12 months the company has reported total profits of €3.76m, up 252% from the prior year. Total revenue was €22.7m over the last 12 months, up 7.8% from the prior year.